159 related articles for article (PubMed ID: 25504679)
1. Manganese increases high mannose glycoform on monoclonal antibody expressed in CHO when glucose is absent or limiting: Implications for use of alternate sugars.
Surve T; Gadgil M
Biotechnol Prog; 2015; 31(2):460-7. PubMed ID: 25504679
[TBL] [Abstract][Full Text] [Related]
2. Chemical inhibitors of hexokinase-2 enzyme reduce lactate accumulation, alter glycosylation processing, and produce altered glycoforms in CHO cell cultures.
Naik HM; Kumar S; Reddy JV; Gonzalez JE; McConnell BO; Dhara VG; Wang T; Yu M; Antoniewicz MR; Betenbaugh MJ
Biotechnol Bioeng; 2023 Sep; 120(9):2559-2577. PubMed ID: 37148536
[TBL] [Abstract][Full Text] [Related]
3. The availability of glucose to CHO cells affects the intracellular lipid-linked oligosaccharide distribution, site occupancy and the N-glycosylation profile of a monoclonal antibody.
Liu B; Spearman M; Doering J; Lattová E; Perreault H; Butler M
J Biotechnol; 2014 Jan; 170():17-27. PubMed ID: 24286971
[TBL] [Abstract][Full Text] [Related]
4. Zinc supplementation decreases galactosylation of recombinant IgG in CHO cells.
Prabhu A; Gadre R; Gadgil M
Appl Microbiol Biotechnol; 2018 Jul; 102(14):5989-5999. PubMed ID: 29749563
[TBL] [Abstract][Full Text] [Related]
5. Modulation of antibody galactosylation through feeding of uridine, manganese chloride, and galactose.
Gramer MJ; Eckblad JJ; Donahue R; Brown J; Shultz C; Vickerman K; Priem P; van den Bremer ET; Gerritsen J; van Berkel PH
Biotechnol Bioeng; 2011 Jul; 108(7):1591-602. PubMed ID: 21328321
[TBL] [Abstract][Full Text] [Related]
6. Amino acid and manganese supplementation modulates the glycosylation state of erythropoietin in a CHO culture system.
Crowell CK; Grampp GE; Rogers GN; Miller J; Scheinman RI
Biotechnol Bioeng; 2007 Feb; 96(3):538-49. PubMed ID: 16937399
[TBL] [Abstract][Full Text] [Related]
7. CHO cell line specific prediction and control of recombinant monoclonal antibody N-glycosylation.
Grainger RK; James DC
Biotechnol Bioeng; 2013 Nov; 110(11):2970-83. PubMed ID: 23737295
[TBL] [Abstract][Full Text] [Related]
8. Combined effects of glycosylation precursors and lactate on the glycoprofile of IgG produced by CHO cells.
Zhang L; Castan A; Stevenson J; Chatzissavidou N; Vilaplana F; Chotteau V
J Biotechnol; 2019 Jan; 289():71-79. PubMed ID: 30423367
[TBL] [Abstract][Full Text] [Related]
9. Recent advances in the understanding of biological implications and modulation methodologies of monoclonal antibody N-linked high mannose glycans.
Shi HH; Goudar CT
Biotechnol Bioeng; 2014 Oct; 111(10):1907-19. PubMed ID: 24975601
[TBL] [Abstract][Full Text] [Related]
10. Low glucose depletes glycan precursors, reduces site occupancy and galactosylation of a monoclonal antibody in CHO cell culture.
Villacrés C; Tayi VS; Lattová E; Perreault H; Butler M
Biotechnol J; 2015 Jul; 10(7):1051-66. PubMed ID: 26058832
[TBL] [Abstract][Full Text] [Related]
11. Tuning a MAb glycan profile in cell culture: Supplementing N-acetylglucosamine to favour G0 glycans without compromising productivity and cell growth.
Blondeel EJ; Braasch K; McGill T; Chang D; Engel C; Spearman M; Butler M; Aucoin MG
J Biotechnol; 2015 Nov; 214():105-12. PubMed ID: 26387447
[TBL] [Abstract][Full Text] [Related]
12. A robust method for increasing Fc glycan high mannose level of recombinant antibodies.
Huang CJ; Lin H; Yang JX
Biotechnol Bioeng; 2015 Jun; 112(6):1200-9. PubMed ID: 25565276
[TBL] [Abstract][Full Text] [Related]
13. Effects of cell culture conditions on antibody N-linked glycosylation--what affects high mannose 5 glycoform.
Pacis E; Yu M; Autsen J; Bayer R; Li F
Biotechnol Bioeng; 2011 Oct; 108(10):2348-58. PubMed ID: 21557201
[TBL] [Abstract][Full Text] [Related]
14. Identification of manipulated variables for a glycosylation control strategy.
St Amand MM; Radhakrishnan D; Robinson AS; Ogunnaike BA
Biotechnol Bioeng; 2014 Oct; 111(10):1957-70. PubMed ID: 24728980
[TBL] [Abstract][Full Text] [Related]
15. Engineering nucleotide sugar synthesis pathways for independent and simultaneous modulation of N-glycan galactosylation and fucosylation in CHO cells.
Prabhu A; Shanmugam D; Gadgil M
Metab Eng; 2022 Nov; 74():61-71. PubMed ID: 36152932
[TBL] [Abstract][Full Text] [Related]
16. Differences in the glycosylation profile of a monoclonal antibody produced by hybridomas cultured in serum-supplemented, serum-free or chemically defined media.
Serrato JA; Hernández V; Estrada-Mondaca S; Palomares LA; Ramírez OT
Biotechnol Appl Biochem; 2007 Jun; 47(Pt 2):113-24. PubMed ID: 17250495
[TBL] [Abstract][Full Text] [Related]
17. Impact of cell culture media additives on IgG glycosylation produced in Chinese hamster ovary cells.
Ehret J; Zimmermann M; Eichhorn T; Zimmer A
Biotechnol Bioeng; 2019 Apr; 116(4):816-830. PubMed ID: 30552760
[TBL] [Abstract][Full Text] [Related]
18. Glycan Residues Balance Analysis - GReBA: A novel model for the N-linked glycosylation of IgG produced by CHO cells.
Zhang L; Wang M; Castan A; Stevenson J; Chatzissavidou N; Hjalmarsson H; Vilaplana F; Chotteau V
Metab Eng; 2020 Jan; 57():118-128. PubMed ID: 31539564
[TBL] [Abstract][Full Text] [Related]
19. Metabolic markers associated with high mannose glycan levels of therapeutic recombinant monoclonal antibodies.
Kang S; Zhang Z; Richardson J; Shah B; Gupta S; Huang CJ; Qiu J; Le N; Lin H; Bondarenko PV
J Biotechnol; 2015 Jun; 203():22-31. PubMed ID: 25797592
[TBL] [Abstract][Full Text] [Related]
20. Modulation of high mannose levels in N-linked glycosylation through cell culture process conditions to increase antibody-dependent cell-mediated cytotoxicity activity for an antibody biosimilar.
Rameez S; Gowtham YK; Nayar G; Mostafa SS
Biotechnol Prog; 2021 Sep; 37(5):e3176. PubMed ID: 34021724
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
